Jupiter Life Line Hospitals (Q2 FY26)

Executive Summary Jupiter Life Line Hospitals reported a steady operational performance for the second quarter of FY26, characterized by double-digit revenue growth and robust operating margins. Management has maintained a pragmatic outlook on Average Revenue Per Occupied Bed (ARPOB), projecting growth to align with inflationary trends, while confirming stability in payor relationships. Key Financial & Operational Highlights Revenue & Margins: The company delivered a 17% year-on-year revenue growth for the quarter ending September 2025. Operating margins remained healthy at approximately 23.4%, signaling efficient cost management alongside top-line expansion. ARPOB Dynamics: Metric Performance: ARPOB for Q2 stood just under ₹65,000, registering a 16% increase compared to the previous period. Growth Drivers: CEO Ankit Thakker attributed the surge predominantly to an improved case mix. The maturing Indore facility is handling increasingly complex medical services, contributing to higher value realization. Surgical Mix: The quarter witnessed a seasonal decline in medical infections (typical for Q2), resulting in a higher proportion of surgical cases, which naturally commands a higher ARPOB. Management Guidance & Outlook Pricing Strategy: Management clarified that ARPOB is viewed as a reflection of patient profiles rather than an actively manipulated lever. Future Projections: Regarding the potential of ARPOB reaching ₹70,000 in FY26, management adopted a conservative stance, stating that future growth is expected to track broadly in line with inflation, avoiding speculative jumps. Risk & Industry Relations Addressing recent industry concerns regarding hospital-insurer friction: Cashless Facilities: The company confirmed that cashless services remain fully operational.